Harold R. Collard, MD, Kevin R. Flaherty, MD and Steven A. Sahn, MD discuss the following:

  • Which tests are the most useful for monitoring IPF? Which are best for assessing the effects of therapy and which are most prognostic? Are there tests that can predict acute exacerbations of IPF?
  • What are the emerging molecular markers which enhance diagnosis or prognosis?
  • What is the role of patient self-assessment in management of IPF and which tools are best?

Upon completion of the activity, participants should be able to:

  • Describe the most appropriate lung function tests to assess and manage patients with IPF

Upon completion of the activity, participants should be able to:

  • Describe the most appropriate lung function tests to assess and manage patients with IPF

Upon completion of the activity, participants should be able to:

  • Describe the most appropriate lung function tests to assess and manage patients with IPF

Access other Therapeutic Areas: